FCBT
MRNA icon

First Citizens Bank & Trust’s Moderna MRNA Stock Holding History

First Citizens Bank & Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,841
Closed -$224K – 359
2023
Q2 		$224K Sell
1,841
-13,979
-88% -$1.86M ﹤0.01% 327
2023
Q1 		$2.43M Buy
15,820
+3,700
+31% +$610K 0.05% 135
2022
Q4 		$2.18M Buy
12,120
+1,063
+10% +$174K 0.07% 130
2022
Q3 		$1.31M Sell
11,057
-3,877
-26% -$588K 0.04% 163
2022
Q2 		$2.13M Buy
14,934
+4,349
+41% +$622K 0.08% 116
2022
Q1 		$1.82M Buy
10,585
+4,749
+81% +$800K 0.07% 129
2021
Q4 		$1.48M Buy
+5,836
New +$1.71M 0.06% 138

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

First Citizens Bank & Trust's MRNA Position: Q3 2023 in Review

First Citizens Bank & Trust sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,841 shares — an estimated $224K sold.

First Citizens Bank & Trust first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $2.43M in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • First Citizens Bank & Trust reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • First Citizens Bank & Trust sold 1,841 Moderna shares in Q3 2023, an estimated $224K.
  • First Citizens Bank & Trust first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • First Citizens Bank & Trust's Moderna position peaked at $2.43M in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on First Citizens Bank & Trust's 13F filing for Q3 2023, filed 30 Oct 2023.